What should patients who are taking CASODEX 150 mg do?
Patients on CASODEX 150 mg (3 x 50 mg pills) daily are advised to discuss treatment discontinuation with their physician. This information does not affect patients taking CASODEX 50 mg daily for metastatic prostate cancer. What is CASODEX? CASODEX is an anti-androgen that interferes with testosterone stimulating prostate cancer cells. It has been developed at a dose of 150 mg (3 x 50mg tablets) daily for early stage prostate cancer. CASODEX comes in tablets containing 50 milligrams (mg) of bicalutamide as the active ingredient. CASODEX comes in blister packs of 15 tablets, 30 tablets per package. What is early prostate cancer? In the early stages, prostate cancer is confined to the prostate gland (localized disease). As the disease progresses, the cancer spreads to other tissues within the pelvis (locally advanced disease) and eventually to other parts of the body (advanced or metastatic prostate cancer). What are the treatment options for localized prostate cancer? The optimal treatme
